Novavax | NVAX - 流动负债

金融业

USD

USD 1.04B

现金及等价物

USD 228.36M

USD 22.1M

USD 850.82M

USD 342.46M

USD 233.31M

USD 20.94M

USD 19.36M

1.54K

EPS每股收益

USD 0.13

股本和储备

USD -144.76M

USD 125.04M

债务利息支出

USD 5.82M

USD 303K

USD 246.3M

USD 1.13B

USD 17.53M

USD 126.2M

USD 20.94M

普通股股本

USD 162.58M

2.01

USD 17.9M

USD 147.14M

销售和管理费用

USD 25.53M

USD 11.46M

贸易债权人

USD 16.1M

应收帐款人

USD 106.45M

	流动负债	更改		日
Adma Biologics	USD 73.54M		4M	2026-03
Agenus	USD 249.24M		74.25M	2026-03
AstraZeneca	USD 32.57B		1.95B	2026-03
BioCryst Pharmaceuticals	USD 195.39M		675K	2026-03
Cassava Sciences	USD 40.11M		3.72M	2026-03
Geron	USD 73.57M		40.25M	2026-03
GlaxoSmithKline	GBP 22.43B		1.04B	2026-03
MannKind	USD 134.56M		36.47M	2026-03
Merck	USD 26.94B		1.38B	2026-03
Minerva Neurosciences	USD 2.29M		381K	2025-12
Moderna	USD 2.4B		408M	2026-03
Novartis	USD 31.37B		4.1B	2026-03
Novavax	USD 342.46M		117.49M	2026-03
Pfizer	USD 34.35B		2.64B	2026-03
Sanofi	EUR 30.01B		1.66B	2026-03
Sarepta Therapeutics	USD 499.16M		596.13M	2026-03
TG Therapeutics	USD 187.11M		33.35M	2026-03